KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Assets: 2012-2025

Historic Return on Assets for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Sep 2025 value amounting to -0.01%.

  • Supernus Pharmaceuticals' Return on Assets fell 6.00% to -0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.01%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of 0.06% for FY2024, which is 5.00% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Return on Assets of -0.01% as of Q3 2025, which was down 128.79% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Return on Assets ranged from a high of 0.07% in Q1 2021 and a low of -0.01% during Q3 2025.
  • Moreover, its 3-year median value for Return on Assets was 0.03% (2023), whereas its average is 0.02%.
  • Over the last 5 years, Supernus Pharmaceuticals' Return on Assets had its largest YoY gain of 6bps in 2025, and its largest YoY loss of 6bps in 2025.
  • Supernus Pharmaceuticals' Return on Assets (Quarterly) stood at 0.03% in 2021, then remained steady at 0.04% in 2022, then decreased by 3bps to 0.00% in 2023, then increased by 5bps to 0.05% in 2024, then fell by 6bps to -0.01% in 2025.
  • Its Return on Assets was -0.01% in Q3 2025, compared to 0.05% in Q2 2025 and 0.05% in Q1 2025.